Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study
Objectives To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. Methods Measles, mumps, rubella (MMR) and diphtheria–tetanus toxoid (DT)-specific immunoglobulin G antibody concentratio...
Saved in:
| Published in | Annals of the rheumatic diseases Vol. 71; no. 6; pp. 948 - 954 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BMJ Publishing Group Ltd and European League Against Rheumatism
01.06.2012
BMJ Publishing Group BMJ Publishing Group LTD |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objectives To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. Methods Measles, mumps, rubella (MMR) and diphtheria–tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1–19 years. Stored patient samples from the period 1997–2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT). Results Corrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p≤0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates. Conclusions Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. |
|---|---|
| AbstractList | Objectives To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. Methods Measles, mumps, rubella (MMR) and diphtheriaâ[euro]"tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1â[euro]"19 years. Stored patient samples from the period 1997â[euro]"2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT). Results Corrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (pâ[per thousand]¤0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates. Conclusions Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. OBJECTIVESTo compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls.METHODSMeasles, mumps, rubella (MMR) and diphtheria-tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1-19 years. Stored patient samples from the period 1997-2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT).RESULTSCorrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p≤0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates.CONCLUSIONSPatients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. ObjectivesTo compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls.MethodsMeasles, mumps, rubella (MMR) and diphtheria-tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1-19 years. Stored patient samples from the period 1997-2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT).ResultsCorrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p less than or equal to 0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates.ConclusionsPatients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. Objectives To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. Methods Measles, mumps, rubella (MMR) and diphtheria–tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1–19 years. Stored patient samples from the period 1997–2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT). Results Corrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p≤0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates. Conclusions Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. Measles, mumps, rubella (MMR) and diphtheria-tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1-19 years. Stored patient samples from the period 1997-2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT). Corrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p≤0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates. Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. OBJECTIVES: To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy controls. METHODS: Measles, mumps, rubella (MMR) and diphtheria-tetanus toxoid (DT)-specific immunoglobulin G antibody concentrations were compared between 400 patients with JIA and 2176 healthy controls aged 1-19 years. Stored patient samples from the period 1997-2006 were obtained from one Dutch centre for paediatric rheumatology. Healthy control samples had been evaluated previously in a nationwide cohort. Participants had been vaccinated according to the Dutch immunisation programme. Antibody concentrations were measured by ELISA (MMR) or multiplex immunoassay (DT). RESULTS: Corrected for age and the number of vaccinations, lower vaccine-specific geometric mean antibody concentrations (GMC) were found in patients with JIA against mumps, rubella, diphtheria and tetanus (p less than or equal to 0.001). Measles-specific GMC were higher (p<0.001) compared with healthy controls. The prevalence of protective antibody concentrations was significantly lower in patients for mumps (OR 0.4; 95% CI 0.3 to 0.6), rubella (OR 0.4; 0.3 to 0.7), diphtheria (OR 0.1; 0.06 to 0.2) and tetanus (OR 0.1; 0.05 to 0.3). Seroprotection rates against measles did not differ between patients and healthy controls (OR 1.4; 0.8 to 2.5). Methotrexate and glucocorticosteroid use did not affect pathogen-specific GMC or seroprotection rates. CONCLUSIONS: Patients with JIA had lower antibody concentrations and seroprotection rates than healthy controls against mumps, rubella, diphtheria and tetanus, but not measles. In these patients, regular assessment of antibody concentrations and further research on responses to other (booster) vaccines are warranted. |
| Author | Heijstek, Marloes W van Gageldonk, Pieter GM Berbers, Guy AM Wulffraat, Nico M |
| Author_xml | – sequence: 1 givenname: Marloes W surname: Heijstek fullname: Heijstek, Marloes W email: m.w.heijstek@umcutrecht.nl organization: Department of Paediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre, Utrecht, The Netherlands – sequence: 2 givenname: Pieter GM surname: van Gageldonk fullname: van Gageldonk, Pieter GM email: m.w.heijstek@umcutrecht.nl organization: Centre for Infectious Disease Control Netherlands, Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment (RIVM), Utrecht, The Netherlands – sequence: 3 givenname: Guy AM surname: Berbers fullname: Berbers, Guy AM email: m.w.heijstek@umcutrecht.nl organization: Centre for Infectious Disease Control Netherlands, Laboratory for Infectious Diseases and Screening, National Institute of Public Health and the Environment (RIVM), Utrecht, The Netherlands – sequence: 4 givenname: Nico M surname: Wulffraat fullname: Wulffraat, Nico M email: m.w.heijstek@umcutrecht.nl organization: Department of Paediatric Immunology, Wilhelmina Children's Hospital, University Medical Centre, Utrecht, The Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25892892$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22172491$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNksuO1DAQRS00iOkZ-AWwhJBYTMCv2Ak7aJ6igQWvZeQ4FcVN4gTbYeh_4-NwupsRYsNIll0ln7oul-4ZOnGjA4TuUfKIUi4fa-d8B_PQ2JAxQmnaiOTqBlpRIYuUSXKCVoQQnolSqlN0FsI2paSgxS10yhhVTJR0hX49t20LHpyBgK3DE_hgQ1xyPLZ4AB16CBd4mIcpHX6uoe_1BW7s1MUOvNVYuwZHiNrNIcXR1mNjk1gN8RLAYdPZvkkP4EsbO7zvWkdrkkJI4rAv70D3sdthM7roxz48wRp7SGGYwET7A7BJccjCko1O9zjEudndRjdb3Qe4czzP0eeXLz6tX2ebD6_erJ9uslqIImZSlmWjNKcgGWOqJFqWopBtrnTLpMiVMA0I0fAyly1vtdGygZwzBdqUeVvwc_TwoDv58fsMIVaDDWYZhINxDhXNcyppzin7P0oYKbjiilwDpbQQUqk8off_Qbfj7NMcEqWUKlTBxUKpA7Ufloe2mrwdtN8lqWqxTfWXbarFNtXBNqny7lF_rgdorur--CQBD46ADkb3rdfOJI0rLi9KllbisgO3eOjn1b323yqZPp1X77-sq6_PPr4jb8tNtUk8O_D1sL12t78B-k_y_g |
| CODEN | ARDIAO |
| CitedBy_id | crossref_primary_10_37489_0235_2990_2020_65_1_2_61_67 crossref_primary_10_1186_s12879_016_2069_y crossref_primary_10_22625_2072_6732_2021_13_2_44_52 crossref_primary_10_1007_s11926_013_0330_6 crossref_primary_10_1016_j_vaccine_2023_07_052 crossref_primary_10_1007_s00508_016_1033_6 crossref_primary_10_1542_gr_32_5_60 crossref_primary_10_1016_j_vaccine_2022_03_041 crossref_primary_10_3389_fped_2022_874711 crossref_primary_10_3899_jrheum_151289 crossref_primary_10_1016_j_vaccine_2020_01_037 crossref_primary_10_1080_21645515_2023_2215108 crossref_primary_10_1007_s00296_021_04833_3 crossref_primary_10_1136_annrheumdis_2013_203429 crossref_primary_10_1016_j_vaccine_2022_06_013 crossref_primary_10_1055_a_1255_8937 crossref_primary_10_1016_j_jvacx_2022_100149 crossref_primary_10_1186_s12969_020_0410_x crossref_primary_10_1016_j_survophthal_2014_03_002 crossref_primary_10_15690_pf_v18i5_2330 crossref_primary_10_15690_vsp_v18i6_2063 crossref_primary_10_1007_s13312_021_2161_2 crossref_primary_10_1177_0961203320973263 crossref_primary_10_1007_s00393_014_1396_x crossref_primary_10_1093_rheumatology_kez096 crossref_primary_10_3389_fped_2022_1098332 crossref_primary_10_5409_wjcp_v12_i2_45 crossref_primary_10_1002_ccr3_1149 crossref_primary_10_1016_j_vaccine_2016_01_027 crossref_primary_10_1080_14760584_2016_1193438 crossref_primary_10_3389_fped_2022_910026 crossref_primary_10_1016_j_vaccine_2016_06_002 crossref_primary_10_1093_rheumatology_keae164 crossref_primary_10_1371_journal_pone_0075951 crossref_primary_10_1371_journal_pone_0207798 crossref_primary_10_1080_03009742_2018_1446100 crossref_primary_10_3389_fimmu_2021_711637 crossref_primary_10_1007_s00431_021_04283_w crossref_primary_10_1002_art_40831 crossref_primary_10_1016_j_idc_2020_02_012 crossref_primary_10_1136_annrheumdis_2019_215882 crossref_primary_10_1111_ddg_14156_g crossref_primary_10_1016_j_berh_2015_02_001 crossref_primary_10_1007_s11926_015_0519_y crossref_primary_10_1038_nrrheum_2013_95 crossref_primary_10_14412_1995_4484_2019_618_625 crossref_primary_10_1097_INF_0000000000002547 crossref_primary_10_1111_ddg_14156 crossref_primary_10_1093_rheumatology_keac408 crossref_primary_10_1093_rheumatology_key142 crossref_primary_10_1007_s00431_022_04418_7 crossref_primary_10_1007_s00431_022_04646_x crossref_primary_10_1093_ibd_izy366 crossref_primary_10_1136_annrheumdis_2012_202561 crossref_primary_10_1586_14760584_2014_943195 crossref_primary_10_1136_annrheumdis_2022_222574 crossref_primary_10_1186_s12969_018_0255_8 crossref_primary_10_1016_j_clim_2020_108588 crossref_primary_10_1186_s12969_021_00594_2 crossref_primary_10_1007_s11926_014_0432_9 |
| ContentType | Journal Article |
| Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 INIST-CNRS Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
| Copyright_xml | – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: 2015 INIST-CNRS – notice: Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions |
| DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 88I 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9- K9. LK8 M0R M0S M1P M2P M7P PQEST PQQKQ PQUKI PRINS Q9U 7X8 7QL 7TS 7U9 C1K H94 |
| DOI | 10.1136/annrheumdis-2011-200637 |
| DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Physical Education Index Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) Physical Education Index Environmental Sciences and Pollution Management |
| DatabaseTitleList | ProQuest Central Student MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1468-2060 |
| EndPage | 954 |
| ExternalDocumentID | 4008557221 10_1136_annrheumdis_2011_200637 22172491 25892892 ark_67375_NVC_WBSM0K9L_L ttp://ard.bmj.com/content/71/6/948.full |
| Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
| GeographicLocations | Netherlands |
| GeographicLocations_xml | – name: Netherlands |
| GroupedDBID | --- .55 .GJ .VT 0R~ 23M 2WC 39C 3O- 3V. 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 88I 8AF 8FE 8FH 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN AAWTL ABAAH ABJNI ABKDF ABMQD ABOCM ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACOFX ACPRK ACTZY ADBBV ADCEG ADFRT ADUGQ ADZCM AEKJL AENEX AFKRA AFWFF AHMBA AHNKE AHQMW AJYBZ AKKEP ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BKNYI BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DWQXO E3Z EBS EJD F5P FRP FYUFA GNUQQ H13 HAJ HCIFZ HMCUK HYE HZ~ IAO IEA IGG IHR INH INR IOF J5H K9- KQ8 L7B LK8 M0R M1P M2P M7P N9A NTWIH NXWIF O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X R53 RHF RHI RMJ RPM RV8 RWL RXW TAE TEORI TR2 UAW UKHRP UYXKK V24 VM9 VVN W2D W8F WH7 WOQ X6Y X7M YFH YOC YQY ZGI ZXP 8RD AEQTP BHJZB BJGMD BSCLL ZA5 AAUGY IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 7QL 7TS 7U9 C1K H94 |
| ID | FETCH-LOGICAL-b448t-6699d7a31e6222790a69486f57af264574cde44d3956f3faca6de5327eac95f83 |
| IEDL.DBID | BENPR |
| ISSN | 0003-4967 |
| IngestDate | Fri Aug 16 00:14:25 EDT 2024 Fri Aug 16 20:33:41 EDT 2024 Fri Aug 16 12:11:26 EDT 2024 Fri Sep 13 05:42:30 EDT 2024 Fri Aug 23 01:19:50 EDT 2024 Thu May 23 23:17:09 EDT 2024 Sun Oct 22 16:06:20 EDT 2023 Wed Jan 17 04:51:55 EST 2024 Wed Aug 21 03:33:30 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Human Rubella Antibody Diseases of the osteoarticular system Rheumatology Diphtheria Infection Persistence Viral disease Cross sectional study Measles Bacteriosis Rheumatism Mumps Tetanus Child |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b448t-6699d7a31e6222790a69486f57af264574cde44d3956f3faca6de5327eac95f83 |
| Notes | local:annrheumdis;71/6/948 ArticleID:annrheumdis-2011-200637 PMID:22172491 href:annrheumdis-71-948.pdf ark:/67375/NVC-WBSM0K9L-L istex:1E859656174A9FA5E9CF2B12FED7D8268B448E9D ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 22172491 |
| PQID | 1777878345 |
| PQPubID | 23462 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1551615312 proquest_miscellaneous_1020837370 proquest_miscellaneous_1011846775 proquest_journals_1777878345 crossref_primary_10_1136_annrheumdis_2011_200637 pubmed_primary_22172491 pascalfrancis_primary_25892892 istex_primary_ark_67375_NVC_WBSM0K9L_L bmj_primary_10_1136_annrheumdis_2011_200637 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-06-01 |
| PublicationDateYYYYMMDD | 2012-06-01 |
| PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Annals of the rheumatic diseases |
| PublicationTitleAlternate | Ann Rheum Dis |
| PublicationYear | 2012 |
| Publisher | BMJ Publishing Group Ltd and European League Against Rheumatism BMJ Publishing Group BMJ Publishing Group LTD |
| Publisher_xml | – name: BMJ Publishing Group Ltd and European League Against Rheumatism – name: BMJ Publishing Group – name: BMJ Publishing Group LTD |
| References | van den Hof, van Gageldonk-Lafeber, van Binnendijk 2003; 21 Plotkin 2010; 17 Tischer, Andrews, Kafatos 2007; 135 Tosh, Kennedy, Vierkant 2009; 22 Wiesik-Szewczyk, Romanowska, Mielnik 2010; 29 Prahalad, Glass 2008; 6 Cunningham-Rundles 2008; 28 Poland, Ovsyannikova, Jacobson 2008; 26 Steens, Mollema, Berbers 2010; 28 Doran, Crowson, Pond 2002; 46 Heijstek, Ott de Bruin, Bijl 2011; 70 Abu-Shakra, Press, Varsano 2002; 29 Ada 2001; 345 Miyamoto, Ono, Barbosa 2011; 20 Di Giovine, Pinto, Olander 2010; 17 Ward, Boulianne, Ratnam 1995; 172 Prelog, Schwarzenbrunner, Sailer-Höck 2008; 58 de Melker, van den Hof, Berbers 2003; 21 Kashef, Ghazizadeh, Derakhshan 2008; 5 Ristow, Douglas, Condemi 1978; 88 de Voer, Mollema, Schepp 2010; 5 Elkayam, Yaron, Caspi 2002; 61 de Haas, van den Hof, Berbers 1999; 123 De Melker, Conyn-van Spaendonck 1998; 121 Elkayam, Paran, Caspi 2002; 34 Borte, Liebert, Borte 2009; 48 Fomin, Caspi, Levy 2006; 65 Andrews, Pebody, Berbers 2000; 125 Petty, Southwood, Manners 2004; 31 Atrasheuskaya, Kulak, Neverov 2008; 26 Thomson, Barrett, Donn 2002; 41 Viana, Ono, Miyamoto 2010; 30 Harmsen, Jongerius, van der Zwan 1992; 30 Skendzel 1996; 106 von Hunolstein, Aggerbeck, Andrews 2000; 18 Hanna-Wakim, Yasukawa, Sung 2008; 197 Williams, Steinberg, Reinertsen 1978; 88 Morbach, Girschick 2009; 42 ter Borg, Horst, Hummel 1991; 59 Tan, Jacobson, Poland 2001; 19 Fessler 2002; 16 van den Hof, Beaumont, Berbers 2003; 131 Giannini, Ruperto, Ravelli 1997; 40 Davidkin, Jokinen, Broman 2008; 197 Oostvogel, van Wijngaarden, van der Avoort 1994; 344 Rümke, Visser 2004; 148 van Gageldonk, van Schaijk, van der Klis 2008; 335 Peltola, Jokinen, Paunio 2008; 8 Grubeck-Loebenstein 2010; 142 |
| References_xml | – volume: 345 start-page: 1042 year: 2001 article-title: Vaccines and vaccination publication-title: N Engl J Med contributor: fullname: Ada – volume: 197 start-page: 1669 year: 2008 article-title: Immune responses to mumps vaccine in adults who were vaccinated in childhood publication-title: J Infect Dis contributor: fullname: Sung – volume: 28 start-page: 7803 year: 2010 article-title: High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study publication-title: Vaccine contributor: fullname: Berbers – volume: 88 start-page: 729 year: 1978 article-title: Influenza immunization in systemic lupus eruthematosus. A double-blind trial publication-title: Ann Intern Med contributor: fullname: Reinertsen – volume: 70 start-page: 1704 year: 2011 article-title: EULAR recommendations for vaccination in paediatric patients with rheumatic diseases publication-title: Ann Rheum Dis contributor: fullname: Bijl – volume: 125 start-page: 127 year: 2000 article-title: The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella publication-title: Epidemiol Infect contributor: fullname: Berbers – volume: 65 start-page: 191 year: 2006 article-title: Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers publication-title: Ann Rheum Dis contributor: fullname: Levy – volume: 59 start-page: 117 year: 1991 article-title: Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation publication-title: Clin Immunol Immunopathol contributor: fullname: Hummel – volume: 335 start-page: 79 year: 2008 article-title: Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to, diphtheria and tetanus publication-title: Bordetella pertussisJ Immunol Methods contributor: fullname: van der Klis – volume: 19 start-page: 2434 year: 2001 article-title: Twin studies of immunogenicity – determining the genetic contribution to vaccine failure publication-title: Vaccine contributor: fullname: Poland – volume: 42 start-page: 373 year: 2009 article-title: Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis publication-title: Autoimmunity contributor: fullname: Girschick – volume: 21 start-page: 4210 year: 2003 article-title: Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay publication-title: Vaccine contributor: fullname: van Binnendijk – volume: 28 start-page: S42 year: 2008 article-title: Autoimmune manifestations in common variable immunodeficiency publication-title: J Clin Immunol contributor: fullname: Cunningham-Rundles – volume: 121 start-page: 637 year: 1998 article-title: Immunosurveillance and the evaluation of national immunization programmes: a population-based approach publication-title: Epidemiol Infect contributor: fullname: Conyn-van Spaendonck – volume: 48 start-page: 144 year: 2009 article-title: Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept publication-title: Rheumatology (Oxford) contributor: fullname: Borte – volume: 34 start-page: 147 year: 2002 article-title: Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus publication-title: Clin Infect Dis contributor: fullname: Caspi – volume: 88 start-page: 786 year: 1978 article-title: Influenza vaccination of patients with systemic lupus erythematosus publication-title: Ann Intern Med contributor: fullname: Condemi – volume: 29 start-page: 605 year: 2010 article-title: Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety publication-title: Clin Rheumatol contributor: fullname: Mielnik – volume: 131 start-page: 703 year: 2003 article-title: Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay publication-title: Epidemiol Infect contributor: fullname: Berbers – volume: 17 start-page: 1055 year: 2010 article-title: Correlates of protection induced by vaccination publication-title: Clin Vaccine Immunol contributor: fullname: Plotkin – volume: 30 start-page: 574 year: 2010 article-title: Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen publication-title: J Clin Immunol contributor: fullname: Miyamoto – volume: 46 start-page: 2287 year: 2002 article-title: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study publication-title: Arthritis Rheum contributor: fullname: Pond – volume: 20 start-page: 736 year: 2011 article-title: Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus publication-title: Lupus contributor: fullname: Barbosa – volume: 40 start-page: 1202 year: 1997 article-title: Preliminary definition of improvement in juvenile arthritis publication-title: Arthritis Rheum contributor: fullname: Ravelli – volume: 30 start-page: 2139 year: 1992 article-title: Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps publication-title: J Clin Microbiol contributor: fullname: van der Zwan – volume: 61 start-page: 623 year: 2002 article-title: Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis publication-title: Ann Rheum Dis contributor: fullname: Caspi – volume: 41 start-page: 1183 year: 2002 article-title: Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients publication-title: Rheumatology (Oxford) contributor: fullname: Donn – volume: 22 start-page: 451 year: 2009 article-title: Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity publication-title: Viral Immunol contributor: fullname: Vierkant – volume: 31 start-page: 390 year: 2004 article-title: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 publication-title: J Rheumatol contributor: fullname: Manners – volume: 16 start-page: 281 year: 2002 article-title: Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis publication-title: Best Pract Res Clin Rheumatol contributor: fullname: Fessler – volume: 197 start-page: 950 year: 2008 article-title: Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up publication-title: J Infect Dis contributor: fullname: Broman – volume: 106 start-page: 170 year: 1996 article-title: Rubella immunity. Defining the level of protective antibody publication-title: Am J Clin Pathol contributor: fullname: Skendzel – volume: 29 start-page: 2555 year: 2002 article-title: Specific antibody response after influenza immunization in systemic lupus erythematosus publication-title: J Rheumatol contributor: fullname: Varsano – volume: 18 start-page: 3287 year: 2000 article-title: European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays publication-title: Vaccine contributor: fullname: Andrews – volume: 123 start-page: 263 year: 1999 article-title: Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination publication-title: Epidemiol Infect contributor: fullname: Berbers – volume: 58 start-page: 2153 year: 2008 article-title: Premature aging of the immune system in children with juvenile idiopathic arthritis publication-title: Arthritis Rheum contributor: fullname: Sailer-Höck – volume: 135 start-page: 787 year: 2007 article-title: Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia publication-title: Epidemiol Infect contributor: fullname: Kafatos – volume: 142 start-page: S116 year: 2010 article-title: Fading immune protection in old age: vaccination in the elderly publication-title: J Comp Pathol contributor: fullname: Grubeck-Loebenstein – volume: 5 year: 2010 article-title: Immunity against serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine publication-title: Neisseria meningitidisPLoS ONE contributor: fullname: Schepp – volume: 344 start-page: 665 year: 1994 article-title: Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992–93 publication-title: Lancet contributor: fullname: van der Avoort – volume: 6 start-page: 11 year: 2008 article-title: A comprehensive review of the genetics of juvenile idiopathic arthritis publication-title: Pediatr Rheumatol Online J contributor: fullname: Glass – volume: 26 start-page: 2111 year: 2008 article-title: Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000–2005 publication-title: Vaccine contributor: fullname: Neverov – volume: 8 start-page: 796 year: 2008 article-title: Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme publication-title: Lancet Infect Dis contributor: fullname: Paunio – volume: 21 start-page: 716 year: 2003 article-title: Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and type b publication-title: Haemophilus influenzaeVaccine contributor: fullname: Berbers – volume: 172 start-page: 1591 year: 1995 article-title: Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination publication-title: J Infect Dis contributor: fullname: Ratnam – volume: 17 start-page: 1282 year: 2010 article-title: External quality assessment for the determination of diphtheria antitoxin in human serum publication-title: Clin Vaccine Immunol contributor: fullname: Olander – volume: 148 start-page: 356 year: 2004 article-title: [Childhood vaccinations anno 2004. I. Effectiveness and acceptance of the Dutch National Vaccination Programme] publication-title: Ned Tijdschr Geneeskd contributor: fullname: Visser – volume: 5 start-page: 181 year: 2008 article-title: Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid publication-title: Iran J Immunol contributor: fullname: Derakhshan – volume: 26 start-page: 6183 year: 2008 article-title: Vaccine immunogenetics: bedside to bench to population publication-title: Vaccine contributor: fullname: Jacobson |
| SSID | ssj0000818 |
| Score | 2.3413637 |
| Snippet | Objectives To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA)... To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA) and healthy... OBJECTIVESTo compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA)... OBJECTIVES: To compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA)... ObjectivesTo compare the persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between patients with juvenile idiopathic arthritis (JIA)... |
| SourceID | proquest crossref pubmed pascalfrancis istex bmj |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 948 |
| SubjectTerms | Adolescent Age Antibodies, Viral - blood Antibodies, Viral - immunology Arthritis Arthritis, Juvenile - drug therapy Arthritis, Juvenile - epidemiology Arthritis, Juvenile - immunology Biological and medical sciences Child Child, Preschool Children Corticoids Cross-Sectional Studies Diphtheria Diphtheria - prevention & control Diphtheria-Tetanus-Pertussis Vaccine - immunology Disease Diseases Diseases of the osteoarticular system Enzyme-linked immunosorbent assay Evaluation Female Glucocorticoids - therapeutic use Health Health care Human viral diseases Humans Immunization Immunoassays Immunoglobulin G Immunoglobulins Immunology Immunosuppressive Agents - therapeutic use Infant Infections Infectious diseases Male Measles Measles - prevention & control Measles-Mumps-Rubella Vaccine - immunology Measurement Medical sciences Methotrexate Methotrexate - therapeutic use Miscellaneous. Osteoarticular involvement in other diseases Mumps Mumps - prevention & control Netherlands - epidemiology Patients Pediatrics Public health Retrospective Studies Rheumatic diseases Rheumatology Rubella Rubella - prevention & control Seroepidemiologic Studies Statistical analysis Studies Tetanus Tetanus - prevention & control Toxoids Vaccines Viral diseases Viral diseases of the respiratory system and ent viral diseases Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye Young Adult Youth |
| Title | Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study |
| URI | http://dx.doi.org/10.1136/annrheumdis-2011-200637 https://api.istex.fr/ark:/67375/NVC-WBSM0K9L-L/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/22172491 https://www.proquest.com/docview/1777878345/abstract/ https://search.proquest.com/docview/1011846775 https://search.proquest.com/docview/1020837370 https://search.proquest.com/docview/1551615312 |
| Volume | 71 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfWVUJICMH4CozKSIgXFjUfjp3wgtjYVMFWIWDQt8iJba1A05KkEvxv_HHcOU6rPVDxlEixI-fucr6P3_kIeW6EDiIjAl9JnvlgEZd-WvDIL8EFinSopDQW5Tvlk0v2bpbM9sikr4VBWGWvE62iVssSY-TjUAiQrTRmyVgWGAUo2_Hr1U8f-0dhntU10xiQYRQyTNgOj0-nHz5utXIapn33PJZx4bBeYWwbvtRXer1Q88a3IUN0s7Ex-qBYfLu2Xw2R9L8QPykbIKHpel_82zi1m9TZHXLbWZf0TScOd8merg7IjQuXPz8gt7ooHe2Kj-6RP29dfxTQFnRe0RVGzxprRtOloQstmx-6OaILYDpc6jWmKeQRVfPVla0clFRWirYaTMx1A_ftvFgiLpE6_Bfti8UpBnypJQCeEUtdYshO72oxf1MHm29eUUlrDbd9GSi1tPEbCxvDD7SH4t4nl2enn08mvuvn4BfgBLY-51mmhIxDzbECNwtAPFjKTSKkAbssEaxUmjEVg89mYiNLyZVO4kjA5pAlJo0fkP1qWelHhKYFC2GC4EGqmDRcRnHJDbyxLHgmg8AjL4F3-ao7sSO3nk5sq697TufI6bzjtEeCnsf_P-WFlYXNeFl_R4ycSPLpl5P86_Gni-B9dp6fe2R0TVg2E6IkzcDbjTxy2EtP7vRHk2-l3SPPNo_hz8d0jqz0ct0gOC9E61HsHBOBjQ3LCnaMwVwpbHwhLOVhJ73bRWL_MpaFj3cv8gm5CbSJOgjdIdlv67V-CsZaW4zIQMzEyP2NfwHvl0IF |
| link.rule.ids | 315,786,790,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,74102,74659 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJgESQjA-VhjDSIgXFi0fjp3wgmAwFbb2hQ36FjmxrZXRtNSJBP8bfxx3jtNqD1Q8JVLsyLm7nO_jdz5CXhqhw9iIMFCS5wFYxFWQlTwOKnCBYh0pKY1D-Y758IJ9nqQTH3CzHlbZ60SnqNW8whj5USQEyFaWsPTt4meAXaMwu-pbaGyRHZbAI5BnMRFrTZxFWd8xj-VceHxXlLgmL8tL3c7U1AYuTIiuNTZD3ypn36_tUTtI7l-ImZQWyGa6fhf_NkjdxnRyj9z1FiV914nAfXJD17vk5sjnzHfJnS4yR7uCowfkzwffEwU0BJ3WdIERM-tMZzo3dKal_aHtIZ0Bo-GybDE1IQ-pmi4uXbWgpLJWtNFgVrYW7ptpOUcsIvWYL9oXiFMM8lJHADwXlvpkkJve1V_-ph4qb99QSZcabvvST-poE1gHFcMPdAfhPiQXJx_Pj4eB7-EQlOD4NQHnea6ETCLNseo2D0EkWMZNKqQBWywVrFKaMZWAn2YSIyvJlU6TWMCGkKcmSx6R7Xpe6z1Cs5JFMEHwMFNMGi7jpOIG3liVPJdhOCCvgXfFojulo3DeTeIqrntOF8jpouP0gIQ9j_9_yisnC6vxcnmFuDiRFuOvx8W3919G4Wl-VpwNyME1YVlNiNMsBw83HpD9XnoKrzNssZbwAXmxegx_O6ZwZK3nrUVAXoQWo9g4Jga7GpYVbhiD-VHY7CJYyuNOeteLxJ5lLI-ebF7kc3JreD6Cr_00Pn1KbgOd4g5Ct0-2m2Wrn4Gx1pQH7o_8C1KLPus |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJk1ICMGAERjDSIgXFi2fdsILgo1qsK5CgkHfIie2tQJNStxI8L_xx3HnOK32QMVTI9WOnLvz-T5-5yPkueYqiDQPfClY7oNFXPlZySK_AhcoUqEUQluU74SdXSYfpunU4Z-Mg1UOOtEqatlUGCM_DjkH2criJD3WDhbx8XT0evHTxw5SmGl17TS2yA6ckgF2M-BTvtbKWZgN3fOSnHGH9Qpj2_ClvVLdXM6Mb0OG6GZjY_Stcv7t2nm1g6T_hfhJYYCEuu998W_j1B5SozvktrMu6ZteHO6SG6reI7sXLn--R271UTraFx_dI39OXX8U0BZ0VtMFRs-MNaNpo-lcCfNDmSM6B6bDT9thmkIcUTlbXNnKQUFFLelSgYnZGXhezsoGcYnU4b_oUCxOMeBLLQHwjljqEkN2el-L-Zs62Lx5RQVtFTwOZaDU0sY3FjaGH2gvxb1PLkfvPp-c-a6fg1-CE7j0GctzyUUcKoYVuHkA4pFkTKdcaLDLUp5UUiWJjMFn07EWlWBSpXHE4XDIU53FD8h23dTqIaFZmYQwgbMgk4nQTERxxTS8sSpZLoLAIy-Bd8Wiv7GjsJ5ObKuvB04XyOmi57RHgoHH_z_lhZWF1XjRfkeMHE-LyZeT4uvbTxfBeT4uxh45vCYsqwlRmuXg7UYeORikp3D6wxRraffIs9XfsPMxnSNq1XQGwXkhWo9845gIbGxYVrBhDOZK4eALYSn7vfSuF4n9y5I8fLR5kU_JLmzGYvx-cv6Y3AQyRT2a7oBsL9tOPQG7bVke2g35FznyQxc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+persistence+of+measles%2C+mumps%2C+rubella%2C+diphtheria+and+tetanus+antibodies+between+children+with+rheumatic+disease+and+healthy+controls%3A+a+retrospective+cross-sectional+study&rft.jtitle=Annals+of+the+rheumatic+diseases&rft.au=Heijstek%2C+Marloes+W&rft.au=van+Gageldonk%2C+Pieter+G+M&rft.au=Berbers%2C+Guy+A+M&rft.au=Wulffraat%2C+Nico+M&rft.date=2012-06-01&rft.eissn=1468-2060&rft.volume=71&rft.issue=6&rft.spage=948&rft_id=info:doi/10.1136%2Fannrheumdis-2011-200637&rft_id=info%3Apmid%2F22172491&rft.externalDocID=22172491 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-4967&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-4967&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-4967&client=summon |